Glioblastoma multiforme (GBM) and beyond: By-passing the blood brain barrier (BBB) via Tumor Treating Fields (TTFields) in vivo

被引：0
作者：
Salvador, E. [1 ]
Kessler, A. [1 ]
Hoermann, J. [1 ]
Burek, M. [2 ]
Brami, C. Tempel [3 ]
Sela, T. Voloshin [3 ]
Giladi, M. [3 ]
Ernestus, R. I. [1 ]
Loehr, M. [1 ]
Foerster, C. [2 ]
Hagemann, C. [1 ]
机构：
[1] Univ Wurzburg, Dept Neurosurg, Tumorbiol Lab, Wurzburg, Germany
[2] Univ Wurzburg, Div Mol Med, Dept Anesthesia & Crit Care, Wurzburg, Germany
[3] Novocure Ltd, Haifa, Israel
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2021年 / 197卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02-8
引用
收藏
页码：S81 / S82
页数：2
相关论文
共 50 条
  • [21] Chemoradiation Treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Patients with Newly Diagnosed Glioblastoma (GBM)
    Cappelli, L.
    Kanyne, A.
    Pan, P. C.
    Cordova, J. S.
    Huang, J.
    Wang, T. J. C.
    Alnahhas, I.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E68 - E68
  • [22] QUALITY OF LIFE (QOL) MANAGEMENT OF GLIOBLASTOMA (GBM) PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) AND CHEMOTHERAPY.
    Saria, Marlon Garzo
    Carter, Joshua
    Kesari, Santosh
    Orosco, Heather
    Turpin, Tiffany
    Piccioni, David
    ONCOLOGY NURSING FORUM, 2016, 43 (02) : 18 - 19
  • [23] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lazaridis, Lazaros
    Schaefer, Niklas
    Kebir, Sied
    Weller, Johannes
    Tzaridis, Theophilos-Dimitrios
    Scheffler, Bjoern
    Pierscianek, Daniela
    Kleinschnitz, Christoph
    Stuschke, Martin
    Sure, Ulrich
    Herrlinger, Ulrich
    Glas, Martin
    NEURO-ONCOLOGY, 2018, 20 : 119 - 120
  • [24] Combination of Tumor Treating Fields (TTFields) with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
    Lazaridis, L.
    Kebir, S.
    Weller, J.
    Tzaridis, T. -D
    Scheffler, B.
    Pierscianek, D.
    Kleinschnitz, C.
    Stuschke, M.
    Sure, U.
    Herrlinger, U.
    Schaefer, N.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S109 - S109
  • [25] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lazaridis, L.
    Schaefer, N.
    Kebir, S.
    Weller, J.
    Tzaridis, T.
    Schaeffler, B.
    Pierscianek, D.
    Kleinschnitz, C.
    Stuschke, M.
    Sure, U.
    Herrlinger, U.
    Glas, M.
    NEURO-ONCOLOGY, 2018, 20 : 230 - 230
  • [26] ASSESSMENT OF TUMOR TREATING FIELDS (TTFIELDS) COMBINED WITH TRICHOSTATIN A (TSA) IN PATIENT-DERIVED GLIOBLASTOMA (GBM) CELLS
    Ma, Manxiu
    Michelhaugh, Sharon
    Mittal, Sandeep
    NEURO-ONCOLOGY, 2021, 23 : 35 - 35
  • [27] Tumor treating fields effects on the blood-brain barrier in vitro and in vivo.
    Salvador, Ellaine
    Kessler, Almuth
    Hoermann, Julia
    Domroese, Dominik
    Schaeffer, Clara
    Burek, Malgorzata
    Tempel-Brami, Catherine
    Voloshin, Tali
    Giladi, Moshe
    Ernestus, Ralf-Ingo
    Loehr, Mario
    Foerster, Carola
    Hagemann, Carsten
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] CHEMORADIATION (CRT) TREATMENT WITH OR WITHOUT CONCURRENT TUMOR-TREATING FIELDS (TTFIELDS) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Cappelli, Louis
    Kayne, Allison
    Pan, Peter
    Cordova, James
    Huang, Jiayi
    Wang, Tony
    Alnahhas, Iyad
    Shi, Wenyin
    NEURO-ONCOLOGY, 2022, 24 : 53 - 53
  • [29] B IN VIVO EFFICACY OF TUMOR TREATING FIELDS (TTFIELDS) FOR GLIOBLASTOMA USING NOVEL MOUSE HEAD ARRAYS
    Zbidat, S.
    Blatt, R.
    Sellevoll, M.
    Gabay, M.
    Schlachet, I
    Cahal, S.
    Davidi, S.
    Tzchori, I
    Haber, A.
    Giladi, M.
    Palti, Y.
    NEURO-ONCOLOGY, 2024, 26
  • [30] IDH1-MUTANT GLIOBLASTOMA (GBM) CELLS FROM A PATIENT POST-TUMOR TREATING FIELDS (TTFIELDS) THERAPY ARE SENSITIVE TO TTFIELDS IN VITRO
    Michelhaugh, Sharon
    Kiousis, Sam
    Klinger, Neil
    Mittal, Sandeep
    NEURO-ONCOLOGY, 2018, 20 : 223 - 223
12345